sorafenib has been researched along with chromone-2-carboxylic acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (chromone-2-carboxylic acid) | Trials (chromone-2-carboxylic acid) | Recent Studies (post-2010) (chromone-2-carboxylic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 27 | 0 | 16 |
| Protein | Taxonomy | sorafenib (IC50) | chromone-2-carboxylic acid (IC50) |
|---|---|---|---|
| Casein kinase II subunit alpha' | Homo sapiens (human) | 5.98 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 5.98 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 5.98 | |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | 5.98 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Long, H; Shi, W; Wang, H; Wang, Q | 1 |
1 other study(ies) available for sorafenib and chromone-2-carboxylic acid
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors.
Topics: Antineoplastic Agents; Casein Kinase II; Chromones; Flavonoids; Humans; Protein Kinase Inhibitors; Structure-Activity Relationship | 2022 |